Combining medical information (MI) and pharmacovigilance (PV) has been shown to drive an array of positive outcomes, including accelerating adverse event intake, improving healthcare professional and patient communications, intelligently connecting enterprise systems and importantly, driving better patient safety. New innovations in connected technologies are finally making it possible to combine elements of these functions in a thoughtful way. However, the change from legacy processes and mindset will be significant and driving employee adoption to see the benefit of these investments will require careful change management. IQVIA’s Annette Williams and Libbie McKenzie explore considerations for leaders looking to combine aspects of their MI and PV functions and how they can effectively roll out this shift to maximize the benefits to their organizations along with patients, providers, and other key stakeholders.

As the U.S. moves from managing COVID-19 to managing a recovery, it is clear that the pandemic lockdowns had a profound impact on how people consume media, how they receive healthcare information, and their expectations changed around how brands connect with them. For marketers, building brand value with customers will be tantamount to marketing success in this brave new world. 

EVERSANA announced the appointment of Bhaskar Sambasivan to President, Patient Services and Chief Strategy Officer.

In the second of a two-part series on improving content management, Veeva Systems discusses how Merck implemented a modular content strategy and is now seeing significant improvements in process efficiency, time to market, customer engagement, and digital transformation.